Agilent Technologies HaloPlexHS Target Enrichment System
Agilent Technologies has launched the HaloPlexHS target enrichment system, designed to improve the speed and accuracy of clinical cancer research. The product will enable researchers to rapidly and accurately identify disease-associated variants in tumour samples - information that can be vital to research in cancer treatments.
The amplicon-based targeted sequencing method is based on Agilent’s HaloPlex technology. The method enables clinical researchers to accurately identify low-frequency somatic variants in solid tumours and haematological cancers. It is a sensitive, specific and rapid method for detection of mutations below 1% for tumour burden monitoring.
The target enrichment technology incorporates more than 1 million unique molecular barcodes for accurate detection of alleles at low frequencies. The molecular barcodes are especially important for cancer researchers who work with heterogeneous samples in which driver mutations can be present in subclonal cell populations.
Phone: 03 9566 1117
Lumiprobe SynaptoProbe Red dye for visualising synaptic vesicles in living neurons
Lumiprobe's SynaptoProbe Red is an analogue of FM 4-64, a widely used red fluorescent dye for...
Parse Biosciences Evercode Low Input Fixation kits for cells and nuclei
The kits empower researchers who have a small number of starting cells or nuclei who ordinarily...
EpigenTek MethylFlash Hydroxymethylated DNA Quantification Kit (Fluorometric)
The kit is a complete set of optimised buffers and reagents to fluorometrically quantify global...
